AJMC June 26, 2022
Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology, discusses the path of telemedicine reimbursement during the pandemic and possible ways it will change after the pandemic, including that some aspects of radiation treatment supervision will go away.
Transcript
How would you characterize telemedicine reimbursement in the oncology setting?
So far, reimbursement is going really well for telemedicine. We know that Medicare has put as part of their proposed fee schedule, the Physician Fee Schedule, reimbursement for telemedicine that will be...